Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer patients: a systematic review

被引：0
|
作者：
Amélie Anota
Astrid Pozet
Hervé Lemasson
Francois-Emery Cotté
Antoine Falcoz
Guillaume Eberst
Guillaume Mouillet
Stéphane Guerzider
Émilie Charton
Virginie Westeel
机构：
[1] University Hospital of Besançon,Methodology and Quality of Life Unit in Oncology (INSERM UMR 1098)
[2] French National Platform Quality of Life and Cancer,Chest Disease Department
[3] Bristol-Myers Squibb,undefined
[4] University Hospital of Besançon,undefined
来源：
Quality of Life Research | 2022年 / 31卷
关键词：
Bias; Immuno-oncology; Open label; Patient-reported outcomes; Quality of life; Randomized controlled trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：645 / 657
页数：12
相关论文
共 50 条
  • [1] Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer patients: a systematic review
    Anota, Amelie
    Pozet, Astrid
    Lemasson, Herve
    Cotte, Francois-Emery
    Falcoz, Antoine
    Eberst, Guillaume
    Mouillet, Guillaume
    Guerzider, Stephane
    Charton, Emilie
    Westeel, Virginie
    QUALITY OF LIFE RESEARCH, 2022, 31 (03) : 645 - 657
  • [2] Impact of open-label design on patient-reported outcomes (PROs) data in randomized clinical trials of immuno-oncology (IO) agents in patients with advanced or metastatic cancer: a 10-year systematic literature review (SLR)
    Anota, Amelie
    Pozet, Astrid
    Lemasson, Herve
    Cotte, Francois-Emery
    Guerzider, Stephane
    Mouillet, Guillaume
    Eberst, Guillaume
    Charton, Emilie
    Westeel, Virginie
    QUALITY OF LIFE RESEARCH, 2020, 29 (SUPPL 1) : S156 - S156
  • [3] Impact of open-label design on patient-reported outcomes (PROs) data in randomized clinical trials of immuno-oncology (IO) agents in patients with advanced or metastatic cancer: A 10-year systematic literature review (SLR)
    Anota, A.
    Pozet, A.
    Lefevre, C.
    Lemasson, H.
    Cotte, F-E.
    Guerzider, S.
    Mouillet, G.
    Eberst, G.
    Charton, E.
    Westeel, V.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review
    Charton E.
    Cuer B.
    Cottone F.
    Efficace F.
    Touraine C.
    Hamidou Z.
    Fiteni F.
    Bonnetain F.
    Woronoff-Lemsi M.-C.
    Bascoul-Mollevi C.
    Anota A.
    Quality of Life Research, 2020, 29 (4) : 867 - 878
  • [5] Assessing the impact of open-label designs in patient-reported outcomes: investigation in oncology clinical trials
    Lord-Bessen, Jennifer
    Signorovitch, James
    Yang, Min
    Georgieva, Mihaela
    Roydhouse, Jessica
    JNCI CANCER SPECTRUM, 2023, 7 (02)
  • [6] Investigating Potential Bias in Patient-Reported Outcomes in Open-label Cancer Trials
    Roydhouse, Jessica K.
    Fiero, Mallorie H.
    Kluetz, Paul G.
    JAMA ONCOLOGY, 2019, 5 (04) : 457 - 458
  • [7] Investigating the impact of open label design on patient-reported outcome results in prostate cancer randomized controlled trials
    Mouillet, Guillaume
    Efficace, Fabio
    Thiery-Vuillemin, Antoine
    Charton, Emilie
    Van Hemelrijck, Mieke
    Sparano, Francesco
    Anota, Amelie
    CANCER MEDICINE, 2020, 9 (20): : 7363 - 7374
  • [8] Patient-Reported Outcomes in Head and Neck Cancer: A Systematic Review of Clinical Trials
    Cao, A. C.
    Lu, J. S.
    Hobday, S. B.
    Cohen, E.
    Sun, L.
    Lukens, J. N.
    Brody, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (05): : E60 - E60
  • [9] Role of Patient-Reported Outcomes in Clinical Trials in Metastatic Colorectal Cancer: A Scoping Review
    Maring, Jan Gerard
    Eijsink, Job F. H.
    Tichelaar, Friso D. D.
    Veluwenkamp-Worawutputtapong, Pawida
    Postma, Maarten J. J.
    Touw, Daan J. J.
    de Groot, Jan Willem B.
    CANCERS, 2023, 15 (04)
  • [10] Immunotherapy related patient-reported outcomes from five randomized controlled trials in patients with triple negative breast cancer: A systematic review
    Sha, Carrie
    Liu, Marie
    Goldberg, Johanna
    Norton, Larry
    Robson, Mark E.
    Zhi, Iris
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345